Skip to main content
TipRanks
Go Ultimate75% OFF

Ab&B Bio-Tech CO., LTD. JS Class H (2627) Financial Statements

2 Followers

Ab&B Bio-Tech CO., LTD. JS Class H Financial Overview

Ab&B Bio-Tech CO., LTD. JS Class H's market cap is currently ¥11.54B. The company's EPS TTM is ¥-0.31; its P/E ratio is -37.71; Ab&B Bio-Tech CO., LTD. JS Class H has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 24Dec 23
Income Statement
Total Revenue¥ 259.61M¥ 52.17M
Gross Profit¥ 151.46M¥ -20.34M
Operating Income¥ -229.09M¥ -422.55M
EBITDA¥ -181.80M¥ -370.16M
Net Income¥ -258.72M¥ -424.74M
Balance Sheet
Cash & Short-Term Investments¥ 132.19M¥ 77.57M
Total Assets¥ 1.61B¥ 1.12B
Total Debt¥ 858.81M¥ 421.42M
Net Debt¥ 726.62M¥ 376.11M
Total Liabilities¥ 1.47B¥ 756.47M
Stockholders' Equity¥ 146.59M¥ 363.27M
Cash Flow
Free Cash Flow¥ -399.68M¥ -597.16M
Operating Cash Flow¥ -199.51M¥ -305.99M
Investing Cash Flow¥ -152.67M¥ -506.00K
Financing Cash Flow¥ 439.06M¥ 335.17M

Currency in CNY

Ab&B Bio-Tech CO., LTD. JS Class H Earnings and Revenue History

-600M-300M0300M-900 %-600 %-300 %0 %EarningsProfit Margin20232024RevenueEarningsProfit Margin

Ab&B Bio-Tech CO., LTD. JS Class H Liabilities to Assets

0600M1.2B1.8B60 %72 %84 %96 %LiabilitiesLiabilities to Assets20232024AssetsLiabilitiesLiabilities to Assets

Ab&B Bio-Tech CO., LTD. JS Class H Cash Flow

-400M-200M0200M400M600M20232024OperatingInvestingFinancing

Ab&B Bio-Tech CO., LTD. JS Class H Forecast EPS vs Actual EPS

-0.1Q2 25Q4 25EPS EstimateBeatMiss